{"recordsFiltered":50008,"recordsTotal":50008,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-days_late&start=38700","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-days_late&start=38100","results":[{"registry_id":"NCT03491683","publication_url":"https://clinicaltrials.gov/study/NCT03491683","title":"An Open-Label, Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With REGN2810 in Subjects With Newly-Diagnosed Glioblastoma (GBM)","has_exemption":false,"start_date":"2018-05-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Inovio Pharmaceuticals","sponsor_slug":"inovio-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03490929","publication_url":"https://clinicaltrials.gov/study/NCT03490929","title":"Contrast Enhanced Ultrasonography for Blunt Abdominal Trauma Imaging in Children","has_exemption":false,"start_date":"2018-06-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03230565","publication_url":"https://clinicaltrials.gov/study/NCT03230565","title":"A Prospective Comparison of Pain and Analgesia in Patients With Continuous Peripheral Nerve Block Catheters Using Continuous Infusion or Scheduled Bolus Infusion","has_exemption":false,"start_date":"2018-06-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03626038","publication_url":"https://clinicaltrials.gov/study/NCT03626038","title":"A.L.P.S. Proximal Humerus Plating System Post-Market Clinical Follow-up Study","has_exemption":false,"start_date":"2018-06-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Zimmer Biomet","sponsor_slug":"zimmer-biomet","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03505320","publication_url":"https://clinicaltrials.gov/study/NCT03505320","title":"A Phase 2 Study of Zolbetuximab (IMAB362) as Monotherapy and in Combination With Chemotherapy and/or Immunotherapy in Subjects With Metastatic or Locally Advanced Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma and Locoregional Gastric or GEJ Adenocarcinoma Whose Are Claudin (CLDN) 18.2 Positive","has_exemption":false,"start_date":"2018-06-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03382457","publication_url":"https://clinicaltrials.gov/study/NCT03382457","title":"Clinical Study of Edwards Cardioband FIT Valve Repair System","has_exemption":false,"start_date":"2018-07-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03525873","publication_url":"https://clinicaltrials.gov/study/NCT03525873","title":"A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy","has_exemption":false,"start_date":"2018-08-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03603912","publication_url":"https://clinicaltrials.gov/study/NCT03603912","title":"Upstream Targeting for the Prevention of Atrial Fibrillation: Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)","has_exemption":false,"start_date":"2018-08-24","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mina Chung, MD","sponsor_slug":"mina-chung-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03412760","publication_url":"https://clinicaltrials.gov/study/NCT03412760","title":"Hydrops: Diagnosing & Redefining Outcomes With Precision Study","has_exemption":false,"start_date":"2018-10-11","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03629171","publication_url":"https://clinicaltrials.gov/study/NCT03629171","title":"Phase II Study of CPX-351 in Combination With Venetoclax in Patients With Acute Myeloid Leukemia (AML)","has_exemption":false,"start_date":"2018-10-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03266627","publication_url":"https://clinicaltrials.gov/study/NCT03266627","title":"A Pilot Study in the Treatment of Refractory Adenovirus (ADV) Infection With Related Donor ADV Cytotoxic T-Lymphocytes (ADV-CTLs)in Children, Adolescents and Young Adult Recipients","has_exemption":false,"start_date":"2018-11-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03266640","publication_url":"https://clinicaltrials.gov/study/NCT03266640","title":"A Pilot Study in the Treatment of Refractory Cytomegalovirus (CMV) Infections With Related Donor CMV Specific Cytotoxic T-cells (CTLs) in Children, Adolescents and Young Adult Recipients","has_exemption":false,"start_date":"2018-11-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06254794","publication_url":"https://clinicaltrials.gov/study/NCT06254794","title":"Effect of Blood Flow Restriction (BFR) Rehabilitation After Achilles Tendon Rupture Reconstruction","has_exemption":false,"start_date":"2018-11-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03712605","publication_url":"https://clinicaltrials.gov/study/NCT03712605","title":"STAMP: Surgically Treated Adjuvant Merkel Cell Carcinoma With Pembrolizumab, a Phase III Trial","has_exemption":false,"start_date":"2018-11-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03747146","publication_url":"https://clinicaltrials.gov/study/NCT03747146","title":"Expanding the Peri-operative Surgical Home Model: ERAS TKR With a Transitional Pain Service (TeleTPS)- Continuous Adductor Canal Catheter Versus Adductor Canal Block for Total Knee Arthroplasty, a Randomized Double-blind Controlled Trial","has_exemption":false,"start_date":"2018-11-16","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03344211","publication_url":"https://clinicaltrials.gov/study/NCT03344211","title":"Immune Activation and Cellular Response From Enzalutamide Alone or With Radium223 in Men With Metastatic, Castration-Resistant Prostate Cancer","has_exemption":false,"start_date":"2018-11-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03637816","publication_url":"https://clinicaltrials.gov/study/NCT03637816","title":"Qualitative Study on Experiences Related to Anorexia and the Effects of Anamorelin and Placebo in Advanced Non-Small-Cell Lung Cancer Patients With Anorexia-Cachexia: A Preliminary Study","has_exemption":false,"start_date":"2018-11-27","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03737955","publication_url":"https://clinicaltrials.gov/study/NCT03737955","title":"A Phase 2 Trial of Fractionated Gemtuzumab Ozogamicin to Eradicate Measurable Residual Disease in Acute Myeloid Leukemia Patients (GO for MRD)","has_exemption":true,"start_date":"2018-11-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03579316","publication_url":"https://clinicaltrials.gov/study/NCT03579316","title":"EFFORT: Efficacy of AZD1775 in Parp Resistance; A Randomized 2-Arm, Non-Comparative Phase 2 Study of AZD1775 Alone or AZD1775 and Olaparib in Women With Ovarian Cancer Who Have Progressed During PARP Inhibition","has_exemption":false,"start_date":"2018-12-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03349528","publication_url":"https://clinicaltrials.gov/study/NCT03349528","title":"A Double-Blind Placebo-Controlled Trial of a Probiotic Supplement to Prevent Relapse and Improve the Clinical Course After Hospitalization for Bipolar Depression","has_exemption":false,"start_date":"2018-12-11","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Sheppard Pratt Health System","sponsor_slug":"sheppard-pratt-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03694756","publication_url":"https://clinicaltrials.gov/study/NCT03694756","title":"TMEM-MRI: A Pilot Feasibility Study of Magnetic Resonance Imaging for Imaging of TMEM (Tumor Microenvironment of Metastasis) in Patients With Operable Breast Cancer","has_exemption":false,"start_date":"2018-12-12","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03793140","publication_url":"https://clinicaltrials.gov/study/NCT03793140","title":"A Phase II Clinical Trial of CPI-613 in Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-grade B-cell Lymphoma With Rearrangements of MYC and BCL2 and/or BCL6","has_exemption":false,"start_date":"2018-12-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03652753","publication_url":"https://clinicaltrials.gov/study/NCT03652753","title":"Prevention of Cartilage Cell Death Following a Pilon Fracture With Intra-articular Injection of N-Acetylcysteine (Pilon NAC)","has_exemption":false,"start_date":"2019-01-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03587701","publication_url":"https://clinicaltrials.gov/study/NCT03587701","title":"A Phase II Placebo Controlled Study of the Effects of Anakinra (Kineret) in Subjects With Corticosteroid-Resistant/Intolerant Meniere's Disease (CR-MD) and Corticosteroid-Resistant/Intolerant Autoimmune Inner Ear Disease Disease (CR-AIED)","has_exemption":false,"start_date":"2019-01-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03593759","publication_url":"https://clinicaltrials.gov/study/NCT03593759","title":"Cardiac Sarcoidosis Multi-Center Randomized Controlled Trial","has_exemption":false,"start_date":"2019-01-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Ottawa Heart Institute Research Corporation","sponsor_slug":"ottawa-heart-institute-research-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03519464","publication_url":"https://clinicaltrials.gov/study/NCT03519464","title":"A Phase 2, Open-Label Study to Assess the Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in Patients With Idiopathic CD4 T Cell Lymphocytopenia","has_exemption":false,"start_date":"2019-02-04","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03697148","publication_url":"https://clinicaltrials.gov/study/NCT03697148","title":"Multiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer","has_exemption":false,"start_date":"2019-02-11","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"ECOG-ACRIN Cancer Research Group","sponsor_slug":"ecog-acrin-cancer-research-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03778060","publication_url":"https://clinicaltrials.gov/study/NCT03778060","title":"Cala TWO Device: Clinical Efficacy and Effects on Regional Brain Metabolism in Essential Tremor Subjects Scheduled to Undergo Deep Brain Stimulation Surgery","has_exemption":false,"start_date":"2019-02-11","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03784326","publication_url":"https://clinicaltrials.gov/study/NCT03784326","title":"Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma","has_exemption":false,"start_date":"2019-02-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03823534","publication_url":"https://clinicaltrials.gov/study/NCT03823534","title":"Post-Op Pain Control for Prophylactic Intramedullary Nailing.","has_exemption":false,"start_date":"2019-02-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"St. Louis University","sponsor_slug":"st-louis-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03769298","publication_url":"https://clinicaltrials.gov/study/NCT03769298","title":"Conversion From Immediate Release Tacrolimus to Envarsus XR® in Simultaneous Pancreas-Kidney Recipients: Assessment of Functional, Safety and Quality of Life Outcomes (CIRTEN SPK)","has_exemption":false,"start_date":"2019-02-27","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03610711","publication_url":"https://clinicaltrials.gov/study/NCT03610711","title":"REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer","has_exemption":false,"start_date":"2019-03-06","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03858205","publication_url":"https://clinicaltrials.gov/study/NCT03858205","title":"Phase II Multi-Institutional Study of Low-Dose (2Gy) Palliative Radiotherapy in the Treatment of Symptomatic Bone Metastases From Multiple Myeloma","has_exemption":false,"start_date":"2019-03-11","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03290534","publication_url":"https://clinicaltrials.gov/study/NCT03290534","title":"Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®","has_exemption":false,"start_date":"2019-03-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"CivaTech Oncology","sponsor_slug":"civatech-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03856632","publication_url":"https://clinicaltrials.gov/study/NCT03856632","title":"Novel Medical Adjunctive Therapy to Catheter Ablation For Atrial Fibrillation (AF)","has_exemption":false,"start_date":"2019-03-18","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03982693","publication_url":"https://clinicaltrials.gov/study/NCT03982693","title":"Trial to Assess Chelation Therapy in Critical Limb Ischemia","has_exemption":false,"start_date":"2019-03-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mt. Sinai Medical Center, Miami","sponsor_slug":"mt-sinai-medical-center-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03909282","publication_url":"https://clinicaltrials.gov/study/NCT03909282","title":"A Randomized Phase II Study Comparing Surgical Excision Versus Neoadjuvant Radiotherapy Followed by Delayed Surgical Excision of Ductal Carcinoma In Situ (NORDIS)","has_exemption":false,"start_date":"2019-03-22","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03513562","publication_url":"https://clinicaltrials.gov/study/NCT03513562","title":"Phase 2 Study of Venetoclax Added to Ibrutinib to Eliminate Ibrutinib Resistance Mutations in CLL","has_exemption":false,"start_date":"2019-03-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03685890","publication_url":"https://clinicaltrials.gov/study/NCT03685890","title":"A Phase Ib/II Randomized Double-blind Placebo Controlled Trial Evaluating the Effect of Nivolumab for Patients With In-transit Melanoma Metastases Treated With Isolated Limb Perfusion - the NivoILP Trial","has_exemption":false,"start_date":"2019-04-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Vastra Gotaland Region","sponsor_slug":"vastra-gotaland-region","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03652428","publication_url":"https://clinicaltrials.gov/study/NCT03652428","title":"Phase I Study of Concurrent Nab-Paclitaxel + Gemcitabine With Hypofractionated, Ablative Proton Therapy for Locally Advanced Pancreatic Cancer","has_exemption":false,"start_date":"2019-04-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03737292","publication_url":"https://clinicaltrials.gov/study/NCT03737292","title":"Comparison of Plasma Concentration And Efficacy Of Liposomal Bupivacaine And Plain Bupivacaine After Intercostal Injections For Pain Management After Thoracoscopy","has_exemption":false,"start_date":"2019-04-09","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Milton S. Hershey Medical Center","sponsor_slug":"milton-s-hershey-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03519269","publication_url":"https://clinicaltrials.gov/study/NCT03519269","title":"Conventional vs. Robotic-Assisted Total Knee Arthroplasty: A Prospective, Randomized Trial of Clinical, Functional, and Radiographic Outcomes","has_exemption":false,"start_date":"2019-04-17","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05589753","publication_url":"https://clinicaltrials.gov/study/NCT05589753","title":"Targeting Chemoreceptor Control of Breathing During Sleep to Mitigate Opioid-Associated Sleep Disordered Breathing","has_exemption":false,"start_date":"2019-05-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03604991","publication_url":"https://clinicaltrials.gov/study/NCT03604991","title":"A Phase II/III Study of Peri-Operative Nivolumab and Ipilimumab in Patients With Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma","has_exemption":false,"start_date":"2019-05-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03839342","publication_url":"https://clinicaltrials.gov/study/NCT03839342","title":"Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations","has_exemption":false,"start_date":"2019-06-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University Health Network, Toronto","sponsor_slug":"university-health-network-toronto","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06541015","publication_url":"https://clinicaltrials.gov/study/NCT06541015","title":"TENS (Transcutaneous Electrical Nerve Stimulation): Effect of Transcutaneous Spinal Direct Current Stimulation on Lower Limb Reflex, Volitional, and Functional Movement Post-stroke","has_exemption":false,"start_date":"2019-06-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03054831","publication_url":"https://clinicaltrials.gov/study/NCT03054831","title":"The Effect of General Anesthesia on Pharmacokinetics and Pharmacogenomics of Liquid Oxycodone in Pediatric Surgical Patients","has_exemption":false,"start_date":"2019-07-08","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06400225","publication_url":"https://clinicaltrials.gov/study/NCT06400225","title":"MATCH Treatment Subprotocol Z1L: BVD-523FB (Ulixertinib) in Patients With Tumors With BRAF Fusions, or With Non-V600E, Non-V600K BRAF Mutations","has_exemption":false,"start_date":"2019-07-24","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03909334","publication_url":"https://clinicaltrials.gov/study/NCT03909334","title":"An Open-Label Randomized Phase II Study of Combining Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor (TKI)-naïve Epidermal Growth Factor Receptor (EGFR)-Mutant Locally Advanced or Metastatic NSCLC","has_exemption":false,"start_date":"2019-07-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Xiuning Le","sponsor_slug":"xiuning-le","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04039750","publication_url":"https://clinicaltrials.gov/study/NCT04039750","title":"Use of Antibiotic Irrigation to Decrease Wound Infections in Pediatric Perforated Appendicitis","has_exemption":false,"start_date":"2019-07-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Prisma Health-Upstate","sponsor_slug":"prisma-health-upstate","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03789552","publication_url":"https://clinicaltrials.gov/study/NCT03789552","title":"A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Phase 3 Study to Confirm the Safety and Efficacy of T89 in Patients With Stable Angina Pectoris, With an Extended Open-label Period to Evaluate the Long-term Safety","has_exemption":false,"start_date":"2019-08-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Tasly Pharmaceuticals, Inc.","sponsor_slug":"tasly-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06554158","publication_url":"https://clinicaltrials.gov/study/NCT06554158","title":"A Phase II Study of Post-Resection Radiation Dose and Treatment Site De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer","has_exemption":false,"start_date":"2019-08-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Georgetown University","sponsor_slug":"georgetown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04029974","publication_url":"https://clinicaltrials.gov/study/NCT04029974","title":"Does the Speed of Robotic Leg Movements During Tilt-table Verticalization Affect Orthostatic Hypotension in Persons With Subacute SCI","has_exemption":false,"start_date":"2019-08-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Methodist Rehabilitation Center","sponsor_slug":"methodist-rehabilitation-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03945162","publication_url":"https://clinicaltrials.gov/study/NCT03945162","title":"A Phase II Clinical Study of Intravesical Ruvidar® in Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (\"NMIBC\") Carcinoma In-Situ (\"CIS\") or Patients Who Are Intolerant to BCG Therapy (\"Study II\")","has_exemption":false,"start_date":"2019-08-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Theralase Technologies Inc.","sponsor_slug":"theralase-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03786692","publication_url":"https://clinicaltrials.gov/study/NCT03786692","title":"TH-138: Phase II Randomized Trial of Carboplatin + Pemetrexed + Bevacizumab, With or Without Atezolizumab in Stage IV Non-squamous NSCLC Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked","has_exemption":false,"start_date":"2019-09-04","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Fox Chase Cancer Center","sponsor_slug":"fox-chase-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03683186","publication_url":"https://clinicaltrials.gov/study/NCT03683186","title":"A Phase 3 Open-label Extension (OLE) Study to Evaluate the Long-term Safety and Efficacy of Ralinepag in Subjects With World Health Organization (WHO) Group 1 Pulmonary Arterial Hypertension (PAH)","has_exemption":false,"start_date":"2019-09-23","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"United Therapeutics","sponsor_slug":"united-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04020276","publication_url":"https://clinicaltrials.gov/study/NCT04020276","title":"A Phase I Study of OAR-Based, Dose Escalated SBRT With Real Time Adaptive MRI Guidance for Liver Metastases","has_exemption":false,"start_date":"2019-11-04","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03841097","publication_url":"https://clinicaltrials.gov/study/NCT03841097","title":"A Phase IV, Prospective, Randomized, Open-label, Comparative Analysis, Single-center Study of Pulse Wave Velocity Evaluation, Tacrolimus TTR and Co-efficient of Tacrolimus Variation of African American Kidney Recipients Receiving Standard of Care Immediate Release Tacrolimus Capsules or Extended Release Tacrolimus Tablets","has_exemption":false,"start_date":"2019-11-11","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Roy D. Bloom, MD","sponsor_slug":"roy-d-bloom-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04115306","publication_url":"https://clinicaltrials.gov/study/NCT04115306","title":"Ph 1/1b/2 Multicenter, Open-Label, FIH Dose Esc & Dose Exp Study to Assess Safety and Tolerability of Orally Administered PMD-026 as a Single Agent and in Combination in Patients With Metastatic or Locally Advanced (Inoperable) RSK2+ Breast Cancer","has_exemption":false,"start_date":"2019-11-14","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Phoenix Molecular Designs","sponsor_slug":"phoenix-molecular-designs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04128709","publication_url":"https://clinicaltrials.gov/study/NCT04128709","title":"Measurement of Bladder Pressure With a Novel External Device (Cystomanometer) - Home Use","has_exemption":false,"start_date":"2019-11-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Christopher Cooper","sponsor_slug":"christopher-cooper","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04182997","publication_url":"https://clinicaltrials.gov/study/NCT04182997","title":"Subjective Intraoperative Use of Epidural Steroid Administration Following Discectomy for Herniated Lumbar Discs Is There a Role? - A Randomized Control Trial","has_exemption":false,"start_date":"2019-11-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04197921","publication_url":"https://clinicaltrials.gov/study/NCT04197921","title":"A Feasibility Clinical Trial of Exablate for Low Intensity Focused Ultrasound Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Abuse Disorders (SUDs)","has_exemption":false,"start_date":"2019-11-27","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"InSightec","sponsor_slug":"insightec","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02846571","publication_url":"https://clinicaltrials.gov/study/NCT02846571","title":"Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye","has_exemption":false,"start_date":"2019-12-05","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Midhat H. Abdulreda","sponsor_slug":"midhat-h-abdulreda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04166877","publication_url":"https://clinicaltrials.gov/study/NCT04166877","title":"Magnesium Infusion for Pain Management in Critically Ill Trauma Patients","has_exemption":false,"start_date":"2019-12-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04164641","publication_url":"https://clinicaltrials.gov/study/NCT04164641","title":"Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration","has_exemption":false,"start_date":"2019-12-09","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04098081","publication_url":"https://clinicaltrials.gov/study/NCT04098081","title":"1911GCCC: Open Label, Phase 2 Trial of Galeterone Combined With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Standard Chemotherapy","has_exemption":false,"start_date":"2019-12-12","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04115631","publication_url":"https://clinicaltrials.gov/study/NCT04115631","title":"A Randomized 3-Arm Phase II Study Comparing 1.) Bendamustine, Rituximab and High Dose Cytarabine (BR/CR) 2.) Bendamustine, Rituximab, High Dose Cytarabine and Acalabrutinib (BR/CR-A), and 3.) Bendamustine, Rituximab and Acalabrutinib (BR-A) in Patients </= 70 Years Old With Untreated Mantle Cell Lymphoma","has_exemption":false,"start_date":"2019-12-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"ECOG-ACRIN Cancer Research Group","sponsor_slug":"ecog-acrin-cancer-research-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04128995","publication_url":"https://clinicaltrials.gov/study/NCT04128995","title":"Surgical or Medical Treatment for Pediatric Type 2 Diabetes","has_exemption":false,"start_date":"2019-12-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04239625","publication_url":"https://clinicaltrials.gov/study/NCT04239625","title":"A Phase 2 Multicenter, Double-Masked, Randomized, Placebo-Controlled Study to Investigate the Long Term Safety, Tolerability, Pharmacokinetics and Effects of ALK-001 on the Progression of Stargardt Disease","has_exemption":false,"start_date":"2019-12-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Alkeus Pharmaceuticals, Inc.","sponsor_slug":"alkeus-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04181684","publication_url":"https://clinicaltrials.gov/study/NCT04181684","title":"Pilot Study of Laser Interstitial Thermal Therapy Followed By Hypofractionated Radiation Therapy for Treatment of Recurrent Gliomas.","has_exemption":false,"start_date":"2020-01-08","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04187105","publication_url":"https://clinicaltrials.gov/study/NCT04187105","title":"BMT-06: Phase II Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Cyclophosphamide and Post-Transplant Cyclophosphamide Conditioning for Partially HLA Mismatched Allogeneic Transplantation in Patients With Acute Leukemia and Myelodysplastic Syndrome (MDS)","has_exemption":false,"start_date":"2020-01-27","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04623931","publication_url":"https://clinicaltrials.gov/study/NCT04623931","title":"Phase II Trial of Treatment Intensification for IDH Wildtype, Non-Histological Glioblastoma, Gliomas (IDH Wildtype Lower Grade Glioma Treatment Intensification)","has_exemption":false,"start_date":"2020-01-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05406999","publication_url":"https://clinicaltrials.gov/study/NCT05406999","title":"A Prospective, Multi-arm, Multi-center Clinical Trial on Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer","has_exemption":false,"start_date":"2020-02-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","sponsor_slug":"the-affiliated-nanjing-drum-tower-hospital-of-nanjing-university-medical-school","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04068753","publication_url":"https://clinicaltrials.gov/study/NCT04068753","title":"Phase II Trial of Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer (OU-SCC-STAR)","has_exemption":false,"start_date":"2020-02-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04152499","publication_url":"https://clinicaltrials.gov/study/NCT04152499","title":"A Phase I-II, First-in-Human Study of SKB264 in Patients With Locally Advanced Unresectable /Metastatic Solid Tumors Who Are Refractory to Available Standard Therapies","has_exemption":false,"start_date":"2020-02-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Klus Pharma Inc.","sponsor_slug":"klus-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03804944","publication_url":"https://clinicaltrials.gov/study/NCT03804944","title":"Converting HR+ Breast Cancer Into an Individualized Vaccine","has_exemption":false,"start_date":"2020-03-17","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04251416","publication_url":"https://clinicaltrials.gov/study/NCT04251416","title":"A Phase II Evaluation of Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2-SN-38 Antibody-drug Conjugate, in Patients With Persistent or Recurrent Endometrial Carcinoma","has_exemption":false,"start_date":"2020-03-17","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04256018","publication_url":"https://clinicaltrials.gov/study/NCT04256018","title":"A Phase 2 Single Center, Single Arm, Open Label Mogamulizumab Combined Upfront With Low Dose Total Skin Electron Beam Therapy (LD TSEBT) in Patients With Mycosis Fungoides (MF) and Sézary Syndrome (SS)","has_exemption":false,"start_date":"2020-03-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03803553","publication_url":"https://clinicaltrials.gov/study/NCT03803553","title":"Early Identification and Treatment of Occult Metastatic Disease in Stage III Colon Cancer","has_exemption":false,"start_date":"2020-04-16","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04128501","publication_url":"https://clinicaltrials.gov/study/NCT04128501","title":"A Phase II Study of Venetoclax in Combination With Azacitidine in the Post-Transplant Setting for AML, T Cell Leukemia, and Mixed Phenotype Acute Leukemia","has_exemption":false,"start_date":"2020-05-05","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04190589","publication_url":"https://clinicaltrials.gov/study/NCT04190589","title":"A Single Center Prospective Study Comparing Robot-assisted and Open Operation With Complete Mesocolic Excision (CME) in Extended Right Colectomy for Colon Cancer in the Right Flexure and Transverse Colon","has_exemption":false,"start_date":"2020-05-18","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Vejle Hospital","sponsor_slug":"vejle-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04240821","publication_url":"https://clinicaltrials.gov/study/NCT04240821","title":"Open-Label Extension Study of Theophylline for Treatment of Pseudohypoparathyroidism","has_exemption":false,"start_date":"2020-05-22","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Jaclyn Tamaroff","sponsor_slug":"jaclyn-tamaroff","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04093167","publication_url":"https://clinicaltrials.gov/study/NCT04093167","title":"A Biomarker-Directed, Multi-Centre Phase II/III Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer","has_exemption":false,"start_date":"2020-05-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Canadian Cancer Trials Group","sponsor_slug":"canadian-cancer-trials-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04216524","publication_url":"https://clinicaltrials.gov/study/NCT04216524","title":"Phase 2 Clinical Trial for Comprehensive Treatment Program for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Tagraxofusp (SL-401) in Combination With HCVAD/Mini-CVD and VENETOCLAX","has_exemption":false,"start_date":"2020-05-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04209660","publication_url":"https://clinicaltrials.gov/study/NCT04209660","title":"A Phase II Study of Lenvatinib Plus Pembrolizumab in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma and Other Salivary Gland Cancers","has_exemption":false,"start_date":"2020-06-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04315701","publication_url":"https://clinicaltrials.gov/study/NCT04315701","title":"Evaluating the PD-1 Checkpoint Inhibitor, Cemiplimab, as Neoadjuvant Therapy in High Risk Localized, Locally Recurrent, and Regionally Advanced Cutaneous Squamous Cell Carcinoma: A Phase II Pilot Study","has_exemption":false,"start_date":"2020-06-17","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04184973","publication_url":"https://clinicaltrials.gov/study/NCT04184973","title":"Efficacy and Safety of the CG-100 Intraluminal Bypass Device in Colorectal and Coloanal Anastomoses: Prospective, Open Label, Randomized Trial","has_exemption":false,"start_date":"2020-06-23","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Colospan Ltd.","sponsor_slug":"colospan-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04115163","publication_url":"https://clinicaltrials.gov/study/NCT04115163","title":"A Pilot Study of Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2020-06-24","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Anne Noonan","sponsor_slug":"anne-noonan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04523493","publication_url":"https://clinicaltrials.gov/study/NCT04523493","title":"A Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter Phase III Study to Compare Toripalimab Combined With Lenvatinib Versus Placebo Combined With Lenvatinib as the 1st-line Therapy for Advanced HCC","has_exemption":false,"start_date":"2020-06-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Shanghai Junshi Bioscience Co., Ltd.","sponsor_slug":"shanghai-junshi-bioscience-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04197596","publication_url":"https://clinicaltrials.gov/study/NCT04197596","title":"A Pilot Study in the Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs) in Children, Adolescents and Young Adult Recipients","has_exemption":false,"start_date":"2020-07-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04375384","publication_url":"https://clinicaltrials.gov/study/NCT04375384","title":"Pilot Phase II Study to Evaluate Effect of Cetuximab Given as Single Agent After Immunotherapy With PD-1 Inhibitors in Patients With Head and Neck Squamous Cell Carcinoma","has_exemption":false,"start_date":"2020-07-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04478279","publication_url":"https://clinicaltrials.gov/study/NCT04478279","title":"A Phase 1-2 Dose-escalation and Expansion Study of ST101 in Patients With Advanced Unresectable and Metastatic Solid Tumors","has_exemption":false,"start_date":"2020-07-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Sapience Therapeutics","sponsor_slug":"sapience-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04562194","publication_url":"https://clinicaltrials.gov/study/NCT04562194","title":"NEVA ONE One-Pass Reperfusion With the NeVa Stent-Retriever EMEA Registry","has_exemption":false,"start_date":"2020-07-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Vesalio","sponsor_slug":"vesalio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03266653","publication_url":"https://clinicaltrials.gov/study/NCT03266653","title":"A Pilot Study in the Treatment of Refractory Epstein-Barr Virus (EBV) Infection With Related Donor EBV Cytotoxic T-Lymphocytes in Children, Adolescents and Young Adult Recipients","has_exemption":false,"start_date":"2020-07-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04560673","publication_url":"https://clinicaltrials.gov/study/NCT04560673","title":"Optimizing Neurofeedback to Treat Chemotherapy Induced Peripheral Neuropathy","has_exemption":false,"start_date":"2020-07-10","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04310007","publication_url":"https://clinicaltrials.gov/study/NCT04310007","title":"A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients With Previously Treated Non-Squamous NSCLC","has_exemption":false,"start_date":"2020-07-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04551170","publication_url":"https://clinicaltrials.gov/study/NCT04551170","title":"Phase 2 Study of Theophylline Treatment for Pseudohypoparathyroidism","has_exemption":false,"start_date":"2020-07-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04861714","publication_url":"https://clinicaltrials.gov/study/NCT04861714","title":"Evaluation of Regeneten Augmentation for Subscapularis Healing After Total Shoulder Arthroplasty (RESTOR)","has_exemption":false,"start_date":"2020-07-14","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04346225","publication_url":"https://clinicaltrials.gov/study/NCT04346225","title":"Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (13C) as a Diagnostic and Response Monitoring Imaging Tool in Advanced Prostate Cancer","has_exemption":false,"start_date":"2020-07-16","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Ivan de Kouchkovsky, MD","sponsor_slug":"ivan-de-kouchkovsky-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04055428","publication_url":"https://clinicaltrials.gov/study/NCT04055428","title":"The Effects of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals (NAUTICAL)","has_exemption":false,"start_date":"2020-08-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04388332","publication_url":"https://clinicaltrials.gov/study/NCT04388332","title":"Comparison of Clinical Outcomes Following ACDF With Instrumentation Using Structural Allograft vs. Tritanium C","has_exemption":false,"start_date":"2020-08-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)","sponsor_slug":"allegheny-singer-research-institute-also-known-as-allegheny-health-network-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04239157","publication_url":"https://clinicaltrials.gov/study/NCT04239157","title":"A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia","has_exemption":false,"start_date":"2020-08-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04466683","publication_url":"https://clinicaltrials.gov/study/NCT04466683","title":"Phase II Protocol of Low-Dose Whole Thorax Megavoltage Radiotherapy for Patients With SARS-COV-2 Pneumonia","has_exemption":false,"start_date":"2020-08-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04516070","publication_url":"https://clinicaltrials.gov/study/NCT04516070","title":"Stereotactic Radiosurgery (SRS) as Definitive Management for a Limited Number of Small Cell Lung Cancer (SCLC) Brain Metastasis","has_exemption":false,"start_date":"2020-08-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04466150","publication_url":"https://clinicaltrials.gov/study/NCT04466150","title":"Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset","has_exemption":false,"start_date":"2020-08-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04262206","publication_url":"https://clinicaltrials.gov/study/NCT04262206","title":"PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)","has_exemption":false,"start_date":"2020-09-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03935295","publication_url":"https://clinicaltrials.gov/study/NCT03935295","title":"Dysport ® (abobotulinumtoxinA) as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis","has_exemption":false,"start_date":"2020-09-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04442022","publication_url":"https://clinicaltrials.gov/study/NCT04442022","title":"A Phase 2/3, Multicenter Randomized Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (RR DLBCL)","has_exemption":false,"start_date":"2020-09-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Karyopharm Therapeutics Inc","sponsor_slug":"karyopharm-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04373473","publication_url":"https://clinicaltrials.gov/study/NCT04373473","title":"A Phase 2a, Randomized, Double-blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation (PRIM-DJ2727) Administered Orally in Combination With Standard of Care Therapy for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis","has_exemption":false,"start_date":"2020-09-14","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04553133","publication_url":"https://clinicaltrials.gov/study/NCT04553133","title":"PHASE 1/2A DOSE ESCALATION, FINDING AND EXPANSION STUDY EVALUATING SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND ANTI TUMOR ACTIVITY OF PF-07104091 AS A SINGLE AGENT AND IN COMBINATION THERAPY","has_exemption":false,"start_date":"2020-09-16","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04861103","publication_url":"https://clinicaltrials.gov/study/NCT04861103","title":"Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)","has_exemption":false,"start_date":"2020-10-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03654053","publication_url":"https://clinicaltrials.gov/study/NCT03654053","title":"Effect of Simvastatin on Hepatic Decompensation and Death in Subjects With High-risk Compensated Cirrhosis","has_exemption":false,"start_date":"2020-10-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03527108","publication_url":"https://clinicaltrials.gov/study/NCT03527108","title":"A Phase 2 Study of Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic Non-Small Cell Lung Carcinoma","has_exemption":false,"start_date":"2020-10-08","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Fox Chase Cancer Center","sponsor_slug":"fox-chase-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04553770","publication_url":"https://clinicaltrials.gov/study/NCT04553770","title":"A Phase II, Multicenter, Open-Label Trial to Evaluate the Safety and Efficacy of Trastuzumab Deruxtecan (DS-8201a) With or Without Anastrozole for HER2 Low Hormone Receptor Positive (HR+) Breast Cancer in the Neoadjuvant Setting","has_exemption":false,"start_date":"2020-10-09","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05011331","publication_url":"https://clinicaltrials.gov/study/NCT05011331","title":"The Effect of a Custom Pillow on Sleep Quality in Patients With Nonoperative Rotator Cuff Syndrome: a Prospective Randomized Study","has_exemption":false,"start_date":"2020-10-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Rhode Island Hospital","sponsor_slug":"rhode-island-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04009109","publication_url":"https://clinicaltrials.gov/study/NCT04009109","title":"A Phase II Study of Lenalidomide, Ixazomib, Dexamethasone, and Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma","has_exemption":false,"start_date":"2020-10-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Alliance Foundation Trials, LLC.","sponsor_slug":"alliance-foundation-trials-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04528680","publication_url":"https://clinicaltrials.gov/study/NCT04528680","title":"Phase 1 / 2 Trial of Blood-brain Barrier Opening With an Implantable Ultrasound Device SonoCloud-9 and Treatment With Albumin-bound Paclitaxel and Carboplatin in Patients With Recurrent Glioblastoma","has_exemption":false,"start_date":"2020-10-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04235257","publication_url":"https://clinicaltrials.gov/study/NCT04235257","title":"Immunogenicity of Fractional Dose of the Bivalent and Nonavalent Intradermal HPV Vaccines.","has_exemption":false,"start_date":"2020-11-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04504123","publication_url":"https://clinicaltrials.gov/study/NCT04504123","title":"MMP-9 Inhibition for Recalcitrant Wet Age-Related Macular Degeneration (AMD)","has_exemption":false,"start_date":"2020-11-04","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04427709","publication_url":"https://clinicaltrials.gov/study/NCT04427709","title":"Generate and Test the Reliability of a Pharmacodynamic Model of Oxytocin on Pupillary Hippus as a Measure of Central Nervous System Activity","has_exemption":false,"start_date":"2020-11-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04331769","publication_url":"https://clinicaltrials.gov/study/NCT04331769","title":"Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study","has_exemption":false,"start_date":"2020-12-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Ancora Heart, Inc.","sponsor_slug":"ancora-heart-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04678895","publication_url":"https://clinicaltrials.gov/study/NCT04678895","title":"Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy, a Small, Randomized, Double-blind, Placebo-controlled Crossover Trial","has_exemption":false,"start_date":"2020-12-22","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04145115","publication_url":"https://clinicaltrials.gov/study/NCT04145115","title":"A Phase II Study of Checkpoint Blockade Immunotherapy in Patients With Somatically Hypermutated Recurrent WHO Grade 4 Glioma","has_exemption":false,"start_date":"2020-12-24","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04690348","publication_url":"https://clinicaltrials.gov/study/NCT04690348","title":"Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study","has_exemption":false,"start_date":"2020-12-24","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04417660","publication_url":"https://clinicaltrials.gov/study/NCT04417660","title":"A Phase II, Open-Label Trial of Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma","has_exemption":false,"start_date":"2020-12-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04181060","publication_url":"https://clinicaltrials.gov/study/NCT04181060","title":"Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2020-12-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04704921","publication_url":"https://clinicaltrials.gov/study/NCT04704921","title":"A Randomized, Partially Masked, Controlled, Phase 2b/3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants With nAMD (ATMOSPHERE)","has_exemption":false,"start_date":"2020-12-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04339699","publication_url":"https://clinicaltrials.gov/study/NCT04339699","title":"STITCH - Prospective Multi Center Comparative Parallel Concurrent Study of the NobleStitch EL Compared to FDA Approved Amplatzer Occluder Device for Closure of Patent Foramen Ovale to Prevent Recurrent Ischemic Stroke","has_exemption":false,"start_date":"2021-01-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Nobles Medical Technologies II Inc","sponsor_slug":"nobles-medical-technologies-ii-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04118387","publication_url":"https://clinicaltrials.gov/study/NCT04118387","title":"Central Sleep Apnea: Physiologic Mechanisms to Inform Treatment","has_exemption":false,"start_date":"2021-01-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04771520","publication_url":"https://clinicaltrials.gov/study/NCT04771520","title":"Phase 2 Study of Avapritinib in Patients With CKIT or PDGFRA Mutation-Positive Malignant Solid Tumors","has_exemption":false,"start_date":"2021-01-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04752826","publication_url":"https://clinicaltrials.gov/study/NCT04752826","title":"Phase 1/2a Open-Label, Dose-Escalation, Multicenter, FIH, Consecutive-Cohort, Clinical Trial of BI-1808, a Monoclonal Antibody to TNFR 2 as a Single Agent and in Combination With Pembrolizumab (MK-3475-D20) in Subjects With Advanced Malignancies","has_exemption":false,"start_date":"2021-01-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"BioInvent International AB","sponsor_slug":"bioinvent-international-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04049539","publication_url":"https://clinicaltrials.gov/study/NCT04049539","title":"Open-Label Phase 2 Trial of Vyxeos in Patients With Intermediate and High-Risk Acute Myeloid Leukemia Who Have Failed an Initial Cycle of Standard Cytarabine and Daunorubicin Chemotherapy","has_exemption":false,"start_date":"2021-01-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04725903","publication_url":"https://clinicaltrials.gov/study/NCT04725903","title":"Extended-Field Lymph Node Proton Irradiation for High Risk Prostate Cancer","has_exemption":false,"start_date":"2021-02-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04978571","publication_url":"https://clinicaltrials.gov/study/NCT04978571","title":"A Prospective Study on the Effect of Auricular Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)","has_exemption":false,"start_date":"2021-02-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Orange County","sponsor_slug":"childrens-hospital-of-orange-county","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04762953","publication_url":"https://clinicaltrials.gov/study/NCT04762953","title":"Phase II Trial of Sequential Systemic Therapy Plus Intraperitoneal Paclitaxel in Gastric/GEJ Cancer Peritoneal Carcinomatosis (STOPGAP)","has_exemption":false,"start_date":"2021-02-18","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04506853","publication_url":"https://clinicaltrials.gov/study/NCT04506853","title":"Single-Sided Deafness and Asymmetric Hearing Loss Post-Approval Study","has_exemption":false,"start_date":"2021-02-22","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Med-El Corporation","sponsor_slug":"med-el-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04633252","publication_url":"https://clinicaltrials.gov/study/NCT04633252","title":"A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer","has_exemption":false,"start_date":"2021-02-23","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04609280","publication_url":"https://clinicaltrials.gov/study/NCT04609280","title":"A Single-arm, Single-stage Phase II Trial of Selective Avoidance of Nodal VolumEs at Minimal Risk (SAVER) in the Contralateral Neck of Patients With p16-positive Oropharynx Cancer","has_exemption":false,"start_date":"2021-03-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04719156","publication_url":"https://clinicaltrials.gov/study/NCT04719156","title":"Evaluation of Intraoperative Tumor Margin Identification With Fluorescent Dye Imaging","has_exemption":false,"start_date":"2021-03-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Kurt Weiss","sponsor_slug":"kurt-weiss","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04408430","publication_url":"https://clinicaltrials.gov/study/NCT04408430","title":"The Safety and Effectiveness of the Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA (SAPIEN 3/Ultra/RESILIA) Valve in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification Who Are Not Candidates for Standard Mitral Valve Surgery.","has_exemption":false,"start_date":"2021-03-08","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayra Guerrero","sponsor_slug":"mayra-guerrero","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03937830","publication_url":"https://clinicaltrials.gov/study/NCT03937830","title":"A Phase II Study of Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinoma (BTC)","has_exemption":false,"start_date":"2021-03-10","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04691804","publication_url":"https://clinicaltrials.gov/study/NCT04691804","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer","has_exemption":false,"start_date":"2021-03-18","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","sponsor_slug":"jiangsu-hengrui-medicine-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04715568","publication_url":"https://clinicaltrials.gov/study/NCT04715568","title":"Occult Cardiovascular Disease With Chronic Exposure to Secondhand Tobacco Smoke","has_exemption":false,"start_date":"2021-03-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04944979","publication_url":"https://clinicaltrials.gov/study/NCT04944979","title":"A Phase III, Open-label, Prospective, Multicenter Study to Assess Efficacy, Safety, and Pharmacokinetics of Kedrion Intravenous Human Normal Immunoglobulin (IVIg) 10% in Pediatric Patients Affected by Primary Immunodeficiency Disease (PID)","has_exemption":false,"start_date":"2021-03-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Kedrion S.p.A.","sponsor_slug":"kedrion-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03819608","publication_url":"https://clinicaltrials.gov/study/NCT03819608","title":"Neuromodulation and Neurorehabilitation for Treatment of Functional Deficits After mTBI and PTSD","has_exemption":false,"start_date":"2021-04-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04099966","publication_url":"https://clinicaltrials.gov/study/NCT04099966","title":"Allogeneic Stem Cell Transplantation for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion - NYMC 588","has_exemption":false,"start_date":"2021-04-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mitchell Cairo","sponsor_slug":"mitchell-cairo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04616781","publication_url":"https://clinicaltrials.gov/study/NCT04616781","title":"Effects of Ketone Ester on Brain Function and Alcohol Consumption in Alcohol Use Disorder","has_exemption":false,"start_date":"2021-04-05","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05212129","publication_url":"https://clinicaltrials.gov/study/NCT05212129","title":"Hypermobile Ehlers-Danlos Syndrome: Efficacy of Non-invasive Vagal Nerve Stimulation and Effects on Brain-Gut Physiology","has_exemption":false,"start_date":"2021-04-05","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06170541","publication_url":"https://clinicaltrials.gov/study/NCT06170541","title":"Ultra-High Resolution Computed Tomography (CT) vs. Conventional CT for Detecting Obstructive Coronary Artery Disease (CAD) The CORE-COMPARE Pilot Study","has_exemption":false,"start_date":"2021-04-05","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04625647","publication_url":"https://clinicaltrials.gov/study/NCT04625647","title":"A Phase II Study of AMG 510 in Participants With Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous Non-Small Cell Lung Cancer (ECOG-ACRIN LUNG-MAP SUB-STUDY)","has_exemption":false,"start_date":"2021-04-16","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05037370","publication_url":"https://clinicaltrials.gov/study/NCT05037370","title":"Topography-guided vs. Wavefront Optimized Corneal Refractive Surgery: A Prospective Contralateral Randomized Double-masked Study","has_exemption":false,"start_date":"2021-04-22","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"59th Medical Wing","sponsor_slug":"59th-medical-wing","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04093388","publication_url":"https://clinicaltrials.gov/study/NCT04093388","title":"Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama","has_exemption":false,"start_date":"2021-04-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04610294","publication_url":"https://clinicaltrials.gov/study/NCT04610294","title":"Operating Room Air Filtration/Sterilization and Surgical Site Infection: A Randomized Multiple Cross-over Cluster Trial","has_exemption":false,"start_date":"2021-05-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04783155","publication_url":"https://clinicaltrials.gov/study/NCT04783155","title":"Effect of Inspiratory Muscle Training on Physiological Function and Clinical Outcomes After Lung Transplant: A Randomized Controlled Trial","has_exemption":false,"start_date":"2021-05-10","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04840979","publication_url":"https://clinicaltrials.gov/study/NCT04840979","title":"Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease With 11C-ER176","has_exemption":false,"start_date":"2021-05-11","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06596252","publication_url":"https://clinicaltrials.gov/study/NCT06596252","title":"Double-blind, Randomized, Non-inferiority Phase III Trial on the Efficacy and Tolerability of 2 mg Once Daily vs. 1 mg Twice Daily Budesonide Orodispersible Tablets in Adults With Eosinophilic Esophagitis","has_exemption":false,"start_date":"2021-05-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Dr. Falk Pharma GmbH","sponsor_slug":"dr-falk-pharma-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04792489","publication_url":"https://clinicaltrials.gov/study/NCT04792489","title":"A Multi-center Single Arm Phase II Study to Evaluate the Safety and Efficacy of Genetically Engineered Autologous Cells Expressing Anti-CD20 and Anti-CD19 Specific Chimeric Antigen Receptor in Subjects With Relapsed and/or Refractory Diffuse Large B Cell Lymphoma","has_exemption":false,"start_date":"2021-05-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Miltenyi Biomedicine GmbH","sponsor_slug":"miltenyi-biomedicine-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04870762","publication_url":"https://clinicaltrials.gov/study/NCT04870762","title":"A Randomized Study of Head and Neck Radiotherapy With or Without Customized 3D Printed Oral Stents","has_exemption":false,"start_date":"2021-05-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07006675","publication_url":"https://clinicaltrials.gov/study/NCT07006675","title":"Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial","has_exemption":false,"start_date":"2021-05-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Major Extremity Trauma Research Consortium","sponsor_slug":"major-extremity-trauma-research-consortium","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04305769","publication_url":"https://clinicaltrials.gov/study/NCT04305769","title":"Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection: a Randomized, Double-blind, Placebo-controlled Trial","has_exemption":false,"start_date":"2021-06-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04464980","publication_url":"https://clinicaltrials.gov/study/NCT04464980","title":"NIDA-CTN-0100: Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)","has_exemption":false,"start_date":"2021-06-08","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04901702","publication_url":"https://clinicaltrials.gov/study/NCT04901702","title":"A Randomized Phase I/II Study of Talazoparib or Temozolomide in Combination With Onivyde in Children With Recurrent Solid Malignancies and Ewing Sarcoma","has_exemption":false,"start_date":"2021-06-09","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05095740","publication_url":"https://clinicaltrials.gov/study/NCT05095740","title":"The Effects of Neuromodulation on Phonatory Function in Laryngeal Dystonia","has_exemption":false,"start_date":"2021-06-10","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"MGH Institute of Health Professions","sponsor_slug":"mgh-institute-of-health-professions","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04860141","publication_url":"https://clinicaltrials.gov/study/NCT04860141","title":"Efficacy of Preoperative Administration of Gabapentin in Managing Intraoperative and Postoperative Pain From Third Molar Extractions.","has_exemption":false,"start_date":"2021-06-16","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Loma Linda University","sponsor_slug":"loma-linda-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04915508","publication_url":"https://clinicaltrials.gov/study/NCT04915508","title":"Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for Adjuvant or Salvage Treatment for Rising PSA After Radical Prostatectomy (EXCALIBUR)","has_exemption":false,"start_date":"2021-06-23","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04783441","publication_url":"https://clinicaltrials.gov/study/NCT04783441","title":"Continuous Glucose Monitoring (CGM) to Improve Glycemic Control in Kidney Transplant Recipients","has_exemption":false,"start_date":"2021-06-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04998916","publication_url":"https://clinicaltrials.gov/study/NCT04998916","title":"MPFC Theta Burst Stimulation as a Treatment Tool for Alcohol Use Disorder: Effects on Drinking and Incentive Salience","has_exemption":false,"start_date":"2021-07-06","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04948203","publication_url":"https://clinicaltrials.gov/study/NCT04948203","title":"SECOVID: A Multi-center, Randomized, Dose-ranging Parallel-group Trial Assessing the Efficacy of Sirolimus in Hospitalized Patients With COVID-19 Pneumonia for the Prevention of Post-COVID Fibrosis","has_exemption":false,"start_date":"2021-07-09","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04870255","publication_url":"https://clinicaltrials.gov/study/NCT04870255","title":"Modulating Probabilities: Prediction, Assessment, and Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS","has_exemption":false,"start_date":"2021-07-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04934683","publication_url":"https://clinicaltrials.gov/study/NCT04934683","title":"Tight Perioperative Blood Pressure Management to Reduce Serious Cardiovascular, Renal, and Cognitive Complications: The GUARDIAN Trial (Induction Agent Sub-Study Comparing Etomidate and Propofol)","has_exemption":false,"start_date":"2021-07-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04934748","publication_url":"https://clinicaltrials.gov/study/NCT04934748","title":"Tight Perioperative Blood Pressure Management to Reduce Serious Cardiovascular, Renal, and Cognitive Complications: The GUARDIAN Trial (Vasopressor Sub-study Comparing Phenylephrine and Norepinephrine)","has_exemption":false,"start_date":"2021-07-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04557891","publication_url":"https://clinicaltrials.gov/study/NCT04557891","title":"Feasibility of Low-Intensity Focused Ultrasound Pulsation (LIFUP) for the Treatment of Generalized Anxiety Disorder (GAD)","has_exemption":false,"start_date":"2021-07-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04551482","publication_url":"https://clinicaltrials.gov/study/NCT04551482","title":"Oxytocin as a Neuroendocrine Therapy for Obesity in Youth","has_exemption":false,"start_date":"2021-07-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04959526","publication_url":"https://clinicaltrials.gov/study/NCT04959526","title":"Comparison of Shear-wave Elastography to State-of-the-art Respiratory Function Testing to Measure the Range of Forces Generated by the Diaphragm Muscle","has_exemption":false,"start_date":"2021-07-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04883242","publication_url":"https://clinicaltrials.gov/study/NCT04883242","title":"Isa-CAPED MM: Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone (Isa-KPd) for Patients With Relapsed/Refractory Multiple Myeloma","has_exemption":false,"start_date":"2021-07-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04912323","publication_url":"https://clinicaltrials.gov/study/NCT04912323","title":"The R3 Vascular Drug-Eluting Bioresorbable Scaffold in Below the Knee Vessels Trial (RESOLV I)","has_exemption":false,"start_date":"2021-08-17","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"R3 Vascular Inc.","sponsor_slug":"r3-vascular-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04968990","publication_url":"https://clinicaltrials.gov/study/NCT04968990","title":"Multi-Center Trial Sponsored by St. Jude Children's Research Hospital for the Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation","has_exemption":false,"start_date":"2021-08-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04724252","publication_url":"https://clinicaltrials.gov/study/NCT04724252","title":"Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children","has_exemption":false,"start_date":"2021-08-23","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05004129","publication_url":"https://clinicaltrials.gov/study/NCT05004129","title":"An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Tideglusib for the Treatment of Congenital or Childhood Onset DM1 (REACH CDM X)","has_exemption":false,"start_date":"2021-08-23","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"AMO Pharma Limited","sponsor_slug":"amo-pharma-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04880226","publication_url":"https://clinicaltrials.gov/study/NCT04880226","title":"Evaluation of Non Significant Risk Operation Magnetic Resonance Imaging for MR Guided Ablation Using the Philips MRI","has_exemption":false,"start_date":"2021-08-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03952299","publication_url":"https://clinicaltrials.gov/study/NCT03952299","title":"Oxybutynin for Post-surgical Bladder Pain and Urgency","has_exemption":false,"start_date":"2021-09-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05178017","publication_url":"https://clinicaltrials.gov/study/NCT05178017","title":"Effectiveness of the Lifestyle Eating and Performance (LEAP) Program for the Treatment of Irritable Bowel Syndrome (IBS)","has_exemption":false,"start_date":"2021-09-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Oxford Biomedical Technologies, Inc.","sponsor_slug":"oxford-biomedical-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05035030","publication_url":"https://clinicaltrials.gov/study/NCT05035030","title":"An Open Label Study to Evaluate the Long-term Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT-EXT)","has_exemption":false,"start_date":"2021-09-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Albireo, an Ipsen Company","sponsor_slug":"albireo-an-ipsen-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04986423","publication_url":"https://clinicaltrials.gov/study/NCT04986423","title":"A Randomized Phase 2b Study of ZEN003694 in Combination With Enzalutamide Versus Enzalutamide Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer","has_exemption":false,"start_date":"2021-09-08","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Zenith Epigenetics","sponsor_slug":"zenith-epigenetics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04896606","publication_url":"https://clinicaltrials.gov/study/NCT04896606","title":"A Pilot Study of SARS-CoV-2 Specific Cytotoxic T Lymphocytes (SARS-CoV-2-CTLs) for Treatment of Mild to Moderate Coronavirus Disease 2019 (COVID-19)","has_exemption":false,"start_date":"2021-09-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04953104","publication_url":"https://clinicaltrials.gov/study/NCT04953104","title":"A Phase II Clinical Trial to Investigate ARID1A and/or KDM6A Mutation and CXCL13 Expression in the Pre-treatment Tumor Samples as a Combinatorial Predictive Biomarker for Immune Checkpoint Therapy in Metastatic Urothelial Cancer","has_exemption":false,"start_date":"2021-09-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04977024","publication_url":"https://clinicaltrials.gov/study/NCT04977024","title":"A Phase 2 Randomized, Multi-center Study of GEO-CMO4S1 (SARS-CoV-2 Vaccine) Versus mRNA SARS-CoV-2 Vaccine in Patients Post Cellular Therapy for Hematological Malignancies","has_exemption":false,"start_date":"2021-09-27","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"GeoVax, Inc.","sponsor_slug":"geovax-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05020574","publication_url":"https://clinicaltrials.gov/study/NCT05020574","title":"Microbiome and Association With Implant Infections: Investigating the Impact of Antibiotics on the Gut and Breast Microbiomes Post-mastectomy With Implant-based Breast Reconstruction","has_exemption":false,"start_date":"2021-09-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05059522","publication_url":"https://clinicaltrials.gov/study/NCT05059522","title":"AVELUMAB MASTER PROTOCOL: AN OPEN-LABEL CONTINUATION STUDY FOR PARTICIPANTS CONTINUING FROM PFIZER-SPONSORED AVELUMAB CLINICAL STUDIES.","has_exemption":false,"start_date":"2021-09-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05079568","publication_url":"https://clinicaltrials.gov/study/NCT05079568","title":"\"A Pilot Study to Assess the Safety, Tolerability and Efficacy of Virtual Reality for the Treatment of Gastroparesis\"","has_exemption":false,"start_date":"2021-10-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04759586","publication_url":"https://clinicaltrials.gov/study/NCT04759586","title":"A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma","has_exemption":false,"start_date":"2021-10-05","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05063851","publication_url":"https://clinicaltrials.gov/study/NCT05063851","title":"The Use of Memantine for Prevention of Alzheimer's Disease","has_exemption":false,"start_date":"2021-10-11","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04708418","publication_url":"https://clinicaltrials.gov/study/NCT04708418","title":"Phase II Randomized Study of Neoadjuvant Pembrolizumab Alone or in Combination With CMP-001 in Patients With Operable Melanoma: Efficacy and Biomarker Study","has_exemption":false,"start_date":"2021-10-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04949100","publication_url":"https://clinicaltrials.gov/study/NCT04949100","title":"Microcurrent for Fibromyalgia, a Double-Blinded, Placebo-Controlled Study","has_exemption":false,"start_date":"2021-10-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Paul Crawford","sponsor_slug":"paul-crawford","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04996173","publication_url":"https://clinicaltrials.gov/study/NCT04996173","title":"Cryospray Therapy for Benign Airway Stenosis: a Randomized Pilot Study","has_exemption":false,"start_date":"2021-10-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04829604","publication_url":"https://clinicaltrials.gov/study/NCT04829604","title":"A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd","has_exemption":false,"start_date":"2021-10-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Ambrx, Inc.","sponsor_slug":"ambrx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04229758","publication_url":"https://clinicaltrials.gov/study/NCT04229758","title":"Restarting Anticoagulation After Traumatic Intracranial Hemorrhage (Restart tICrH): a Prospective Randomized Open Label Blinded Endpoint (PROBE) Pragmatic Time-dose, Response Adaptive Clinical Trial","has_exemption":false,"start_date":"2021-10-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05015881","publication_url":"https://clinicaltrials.gov/study/NCT05015881","title":"Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder","has_exemption":false,"start_date":"2021-11-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05110144","publication_url":"https://clinicaltrials.gov/study/NCT05110144","title":"A Randomized, Double-blind, Placebo-controlled, Dose-escalation Study Evaluating the Efficacy of Two Doses of Duloxetine & Amitriptyline in Subjects With Refractory Chronic Cough","has_exemption":false,"start_date":"2021-11-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04597372","publication_url":"https://clinicaltrials.gov/study/NCT04597372","title":"The Impact of Tamsulosin on Duration of Post-Operative Urinary Retention in Women Undergoing Pelvic Reconstructive Surgery- A Double Blind, Randomized, Placebo-Controlled Study","has_exemption":false,"start_date":"2021-11-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)","sponsor_slug":"allegheny-singer-research-institute-also-known-as-allegheny-health-network-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05058287","publication_url":"https://clinicaltrials.gov/study/NCT05058287","title":"Topical Epidural Steroid Usage in Patients Undergoing Posterior Lumbar Decompression: A Randomized Control Trial","has_exemption":false,"start_date":"2021-11-05","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05065216","publication_url":"https://clinicaltrials.gov/study/NCT05065216","title":"Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)","has_exemption":false,"start_date":"2021-11-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"DiaMedica Therapeutics Inc","sponsor_slug":"diamedica-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05131178","publication_url":"https://clinicaltrials.gov/study/NCT05131178","title":"Double Blind Randomized Trial of Post-operative Cesarean Continuous Infusion of Bupivacaine Versus Placebo for Local Incisional Pain Control","has_exemption":false,"start_date":"2021-11-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04692818","publication_url":"https://clinicaltrials.gov/study/NCT04692818","title":"3D Multimodal Ultrasound Imaging for Breast Cancer","has_exemption":false,"start_date":"2021-11-10","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04707885","publication_url":"https://clinicaltrials.gov/study/NCT04707885","title":"Clinical Utility of Residual Hearing in the Cochlear Implant Ear","has_exemption":false,"start_date":"2021-11-10","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04819841","publication_url":"https://clinicaltrials.gov/study/NCT04819841","title":"A Phase I/II Study of Nula-cel in Autologous CD34+ Hematopoietic Stem Cells to Convert HbS to HbA for Treating Severe Sickle Cell Disease","has_exemption":false,"start_date":"2021-11-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Kamau Therapeutics","sponsor_slug":"kamau-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05729542","publication_url":"https://clinicaltrials.gov/study/NCT05729542","title":"Randomized Controlled Trial Comparing Clinical Outcomes of Patients Treated Surgically With Suture Button Versus Fibulink Fixation for Acute Ankle Syndesmosis Injuries","has_exemption":false,"start_date":"2021-11-18","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04794530","publication_url":"https://clinicaltrials.gov/study/NCT04794530","title":"COCOA Flavanols to Improve Walking Performance in PAD: the COCOA-PAD II Trial","has_exemption":false,"start_date":"2021-11-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05205330","publication_url":"https://clinicaltrials.gov/study/NCT05205330","title":"An Open-label, Single-arm, Phase Ib/IIa Trial to Evaluate the Safety and Efficacy of the EP4 Receptor Antagonist Vorbipiprant (CR6086) in Combination With the PD-1 Inhibitor Balstilimab (AGEN2034), in Patients With Pretreated Mismatch-repair-proficient and Microsatellite Stable Metastatic Colorectal Cancer, and Other Metastatic GI Cancers.","has_exemption":false,"start_date":"2021-11-23","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Rottapharm Biotech","sponsor_slug":"rottapharm-biotech","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05173714","publication_url":"https://clinicaltrials.gov/study/NCT05173714","title":"Sit Less, Interact and Move More (SLIMM) 2 Study","has_exemption":false,"start_date":"2021-12-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Srinvasan Beddhu","sponsor_slug":"srinvasan-beddhu","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05196984","publication_url":"https://clinicaltrials.gov/study/NCT05196984","title":"Acute Exposure of Individuals With Down Syndrome to Gamma Frequency Stimulation","has_exemption":false,"start_date":"2021-12-06","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts Institute of Technology","sponsor_slug":"massachusetts-institute-of-technology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05000294","publication_url":"https://clinicaltrials.gov/study/NCT05000294","title":"Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types","has_exemption":false,"start_date":"2021-12-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05241210","publication_url":"https://clinicaltrials.gov/study/NCT05241210","title":"Real-Time Feedback (RTFB) to Improve Colonoscopy","has_exemption":false,"start_date":"2021-12-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04019262","publication_url":"https://clinicaltrials.gov/study/NCT04019262","title":"Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma: Comparison of Two Established Schedules","has_exemption":false,"start_date":"2021-12-14","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"John Flickinger","sponsor_slug":"john-flickinger","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04933149","publication_url":"https://clinicaltrials.gov/study/NCT04933149","title":"Ketamine Infusion for Treatment of Chronic Neuropathic Pain in Traumatic Brachial Plexus Injuries, a Prospective Randomized Control Study","has_exemption":false,"start_date":"2021-12-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05167721","publication_url":"https://clinicaltrials.gov/study/NCT05167721","title":"Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy","has_exemption":false,"start_date":"2021-12-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04989946","publication_url":"https://clinicaltrials.gov/study/NCT04989946","title":"Phase I/II Trial of Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer","has_exemption":false,"start_date":"2021-12-16","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05013255","publication_url":"https://clinicaltrials.gov/study/NCT05013255","title":"Pioglitazone Therapy Targeting Fatigue in Breast Cancer","has_exemption":false,"start_date":"2021-12-23","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"West Virginia University","sponsor_slug":"west-virginia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04521699","publication_url":"https://clinicaltrials.gov/study/NCT04521699","title":"Examination of the Impact of CalmiGo's Stress Management Device on Vascular Health and Cardiovascular Disease Risk , and Markers of Mental Stress in Patients Following a Myocardial Infarction Participating in Clinically Indicated Cardiac Rehabilitation","has_exemption":false,"start_date":"2022-01-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05170919","publication_url":"https://clinicaltrials.gov/study/NCT05170919","title":"An Efficacy Study Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer","has_exemption":false,"start_date":"2022-01-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Englewood Hospital and Medical Center","sponsor_slug":"englewood-hospital-and-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05210114","publication_url":"https://clinicaltrials.gov/study/NCT05210114","title":"Cutaneous Hydration Assessment in Sickle Cell Disease","has_exemption":false,"start_date":"2022-01-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Enrico Novelli","sponsor_slug":"enrico-novelli","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05263050","publication_url":"https://clinicaltrials.gov/study/NCT05263050","title":"GU-187: Phase II Trial of Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors","has_exemption":false,"start_date":"2022-01-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Fox Chase Cancer Center","sponsor_slug":"fox-chase-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04870944","publication_url":"https://clinicaltrials.gov/study/NCT04870944","title":"A Phase 1/2 Trial of CBL0137 (NSC# 825802) in Patients With Relapsed or Refractory Solid Tumors Including CNS Tumors and Lymphoma","has_exemption":false,"start_date":"2022-01-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05262023","publication_url":"https://clinicaltrials.gov/study/NCT05262023","title":"A Phase 1/2, Multicenter, Randomized, Placebo-Controlled, Double Blind Single Dose and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in Healthy Participants and Participants With Frontotemporal Dementia Followed by an Open-Label Extension","has_exemption":false,"start_date":"2022-02-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Denali Therapeutics Inc.","sponsor_slug":"denali-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05004987","publication_url":"https://clinicaltrials.gov/study/NCT05004987","title":"Depression Treatment and Aβ Dynamics: A Study of Alzheimer's Disease Risk (ABD Study)","has_exemption":false,"start_date":"2022-02-04","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04751370","publication_url":"https://clinicaltrials.gov/study/NCT04751370","title":"A Phase II Study of Neoadjuvant Nivolumab Plus Ipilimumab and Short-Course Radiation in MSI-H/dMMR Locally Advanced Rectal Adenocarcinoma","has_exemption":false,"start_date":"2022-02-08","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05085288","publication_url":"https://clinicaltrials.gov/study/NCT05085288","title":"The PROTECT 2 Study: Pressure Injury Treatment by Intermittent Electrical Stimulation: A Randomized, Controlled Trial","has_exemption":false,"start_date":"2022-02-08","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05802680","publication_url":"https://clinicaltrials.gov/study/NCT05802680","title":"Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation","has_exemption":false,"start_date":"2022-02-09","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Francisco Gonzalez-Lima, PhD","sponsor_slug":"francisco-gonzalez-lima-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05269316","publication_url":"https://clinicaltrials.gov/study/NCT05269316","title":"A First-in-human, Phase 1/2, Open-label, Multi-center, Dose-escalation and Dose-expansion Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of the ATR Inhibitor IMP9064 Monotherapy and in Combination With PARP Inhibitor Senaparib in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2022-02-11","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Impact Therapeutics, Inc.","sponsor_slug":"impact-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05401292","publication_url":"https://clinicaltrials.gov/study/NCT05401292","title":"Skin Preparation for Elective Foot and Ankle Surgery","has_exemption":false,"start_date":"2022-02-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05004727","publication_url":"https://clinicaltrials.gov/study/NCT05004727","title":"Preventing Arthritis in a Multi-Center Psoriasis At-Risk Cohort","has_exemption":false,"start_date":"2022-02-16","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04922281","publication_url":"https://clinicaltrials.gov/study/NCT04922281","title":"Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation (ICM REDUCE-AF)","has_exemption":false,"start_date":"2022-02-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03568292","publication_url":"https://clinicaltrials.gov/study/NCT03568292","title":"Effects of Virtual Reality on Pain and Anxiety in Cancer Patients Undergoing Painful Procedures","has_exemption":false,"start_date":"2022-03-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04865679","publication_url":"https://clinicaltrials.gov/study/NCT04865679","title":"Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends","has_exemption":false,"start_date":"2022-03-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Axogen Corporation","sponsor_slug":"axogen-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01297400","publication_url":"https://clinicaltrials.gov/study/NCT01297400","title":"Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns","has_exemption":false,"start_date":"2022-03-11","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Skingenix, Inc.","sponsor_slug":"skingenix-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05077800","publication_url":"https://clinicaltrials.gov/study/NCT05077800","title":"A Phase II Study of FOLFIRINOX Combined With the Glycogen Synthase Kinase-3 Beta (GSK-3 β) Inhibitor Elraglusib and the Transforming Growth Factor-β (TGF-β) Inhibitor Losartan in Patients With Untreated Metastatic Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2022-03-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Colin D. Weekes, M.D., PhD","sponsor_slug":"colin-d-weekes-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05477576","publication_url":"https://clinicaltrials.gov/study/NCT05477576","title":"Phase 1b/3 Global, Randomized, Controlled, Open-label Trial Comparing Treatment With RYZ101 to Standard of Care Therapy in Subjects With Inoperable, Advanced, SSTR+, Well-differentiated GEP-NETs That Have Progressed Following Prior 177Lu-SSA Therapy","has_exemption":false,"start_date":"2022-03-24","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"RayzeBio, Inc.","sponsor_slug":"rayzebio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05232929","publication_url":"https://clinicaltrials.gov/study/NCT05232929","title":"Long-term Follow-up Study of Patients With Spinal Muscular Atrophy Receiving Risdiplam Treatment","has_exemption":false,"start_date":"2022-03-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Genentech, Inc.","sponsor_slug":"genentech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05024097","publication_url":"https://clinicaltrials.gov/study/NCT05024097","title":"A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.","has_exemption":false,"start_date":"2022-03-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06063148","publication_url":"https://clinicaltrials.gov/study/NCT06063148","title":"Neonatal Pulse Oximetry Disparities Due to Skin Pigmentation","has_exemption":false,"start_date":"2022-04-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05895006","publication_url":"https://clinicaltrials.gov/study/NCT05895006","title":"Intrinsic and Novelty-related Sensory Cortical (SC) Disinhibition and Sensory-Prefrontal-cortex-Amygdala (SPA) Pathology in Posttraumatic Stress Disorder (PTSD) (Aims 1 & 2; Expts. 1a &1b)","has_exemption":false,"start_date":"2022-04-05","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04592744","publication_url":"https://clinicaltrials.gov/study/NCT04592744","title":"Intraoperative Angiotensin 2 for the Prevention of Kidney Injury After Liver Transplant","has_exemption":false,"start_date":"2022-04-08","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05303532","publication_url":"https://clinicaltrials.gov/study/NCT05303532","title":"ROSY-D: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab and Are Judged by the Investigator to Clinically Benefit From Continued Treatment","has_exemption":false,"start_date":"2022-04-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04329065","publication_url":"https://clinicaltrials.gov/study/NCT04329065","title":"A Phase II Study of Concurrent WOKVAC Vaccination With Neoadjuvant Chemotherapy and HER2-Targeted Monoclonal Antibody Therapy","has_exemption":false,"start_date":"2022-04-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05282277","publication_url":"https://clinicaltrials.gov/study/NCT05282277","title":"Examining the Effects of Estradiol on Neural and Molecular Response to Rewards in Perimenopausal-Onset Anhedonia and Psychosis","has_exemption":false,"start_date":"2022-04-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05312710","publication_url":"https://clinicaltrials.gov/study/NCT05312710","title":"Phase 2 Study to Evaluate the Safety and Efficacy of APG-157 as Neoadjuvant/Induction Therapy for Patients With Head and Neck Squamous Cell Cancer (HNSCC) of the Oral Cavity and/or Oropharynx","has_exemption":false,"start_date":"2022-04-22","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Aveta Biomics, Inc.","sponsor_slug":"aveta-biomics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04403139","publication_url":"https://clinicaltrials.gov/study/NCT04403139","title":"VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination","has_exemption":false,"start_date":"2022-04-27","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05061004","publication_url":"https://clinicaltrials.gov/study/NCT05061004","title":"Cephea Early Feasibility Study","has_exemption":false,"start_date":"2022-04-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04956341","publication_url":"https://clinicaltrials.gov/study/NCT04956341","title":"Auricular Acupuncture for Sleep Disturbances: A Randomized Control Trial","has_exemption":false,"start_date":"2022-05-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Paul Crawford","sponsor_slug":"paul-crawford","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04918186","publication_url":"https://clinicaltrials.gov/study/NCT04918186","title":"An Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer","has_exemption":false,"start_date":"2022-05-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Canadian Cancer Trials Group","sponsor_slug":"canadian-cancer-trials-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05296681","publication_url":"https://clinicaltrials.gov/study/NCT05296681","title":"A Randomized Trial of Microbiotic Product (NBT-NM108) to Promote Microbiome Health and Improve Chemotherapy Delivery","has_exemption":false,"start_date":"2022-05-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Howard S. Hochster, MD","sponsor_slug":"howard-s-hochster-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05347771","publication_url":"https://clinicaltrials.gov/study/NCT05347771","title":"Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents (PANDA) (CAUSE-01)","has_exemption":false,"start_date":"2022-05-04","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05124912","publication_url":"https://clinicaltrials.gov/study/NCT05124912","title":"REMASTer: REcurrent Brain Metastases After SRS Trial","has_exemption":false,"start_date":"2022-05-10","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Monteris Medical","sponsor_slug":"monteris-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05327959","publication_url":"https://clinicaltrials.gov/study/NCT05327959","title":"A.L.P.S. Clavicle Plating System for Clavicle Fracture Fixation Post-Market Follow-up Study (Implants and Instrumentation)","has_exemption":false,"start_date":"2022-05-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Zimmer Biomet","sponsor_slug":"zimmer-biomet","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05304481","publication_url":"https://clinicaltrials.gov/study/NCT05304481","title":"A Phase II Study to Evaluate the Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma (HCC) Patients After Curative Treatment","has_exemption":false,"start_date":"2022-05-14","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Lukas Biomedical Inc.","sponsor_slug":"lukas-biomedical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05257590","publication_url":"https://clinicaltrials.gov/study/NCT05257590","title":"A Phase 2, Open-Label Study of CVM-1118 in Combination With Nivolumab in Subjects With Unresectable Advanced Hepatocellular Carcinoma","has_exemption":false,"start_date":"2022-05-23","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"TaiRx, Inc.","sponsor_slug":"tairx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06148285","publication_url":"https://clinicaltrials.gov/study/NCT06148285","title":"Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Recovery","has_exemption":false,"start_date":"2022-05-24","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"LCMC Health","sponsor_slug":"lcmc-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05421689","publication_url":"https://clinicaltrials.gov/study/NCT05421689","title":"A Multi-Center, Double-Blind, Randomized Placebo-Controlled Investigation of Autologous Muscle Derived Cells (AMDC) for the Treatment of Tongue Dysphagia Resulting From the Treatment of Head and Neck Cancer","has_exemption":false,"start_date":"2022-05-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05270525","publication_url":"https://clinicaltrials.gov/study/NCT05270525","title":"A Randomized, Double-Blind, Placebo-Controlled, Two-period Cross-over Study of the Effect of Ensifentrine on Sputum Markers of Inflammation in Patients With COPD","has_exemption":false,"start_date":"2022-05-27","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA","sponsor_slug":"verona-pharma-inc-a-subsidiary-of-merck-co-inc-rahway-new-jersey-usa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04099342","publication_url":"https://clinicaltrials.gov/study/NCT04099342","title":"Enhanced Spatial Targeting in ECT Utilizing Focally Electrically-administered Seizure Therapy (FEAST)","has_exemption":false,"start_date":"2022-06-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04411225","publication_url":"https://clinicaltrials.gov/study/NCT04411225","title":"Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis: Understanding the Mechanism and Mediators of Action","has_exemption":false,"start_date":"2022-06-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05425004","publication_url":"https://clinicaltrials.gov/study/NCT05425004","title":"A Phase II Study of Cabozantinib for Patients With Recurrent or Progressive Meningioma","has_exemption":false,"start_date":"2022-06-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Baptist Health South Florida","sponsor_slug":"baptist-health-south-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04733534","publication_url":"https://clinicaltrials.gov/study/NCT04733534","title":"SEN-SURVIVORS: An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer","has_exemption":false,"start_date":"2022-06-06","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05351593","publication_url":"https://clinicaltrials.gov/study/NCT05351593","title":"A Phase I/II Study of Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma","has_exemption":false,"start_date":"2022-06-08","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"James Rubenstein","sponsor_slug":"james-rubenstein","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05081882","publication_url":"https://clinicaltrials.gov/study/NCT05081882","title":"Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava","has_exemption":false,"start_date":"2022-06-09","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05970549","publication_url":"https://clinicaltrials.gov/study/NCT05970549","title":"DIVE: Deployment of Irrigating Intraventricular Catheter System for Intraventricular Hemorrhage","has_exemption":false,"start_date":"2022-06-14","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05291871","publication_url":"https://clinicaltrials.gov/study/NCT05291871","title":"Immunogenicity of Fractional Dose of the HPV Vaccines","has_exemption":false,"start_date":"2022-06-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04523727","publication_url":"https://clinicaltrials.gov/study/NCT04523727","title":"A 36-week, Single-Arm, Open-label Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease","has_exemption":false,"start_date":"2022-06-16","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Keryx Biopharmaceuticals","sponsor_slug":"keryx-biopharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05412381","publication_url":"https://clinicaltrials.gov/study/NCT05412381","title":"Platelet Rich Plasma (PRP) Treatment of the Anterior Cruciate Ligament Injured Knee to Decrease the Risk of Post-traumatic Osteoarthritis (PTOA): a Randomized Double-blind Controlled Trial","has_exemption":false,"start_date":"2022-06-27","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05335252","publication_url":"https://clinicaltrials.gov/study/NCT05335252","title":"Dronabinol for the Treatment of Postoperative Pain After Arthroscopic Surgery: a Pilot Randomized Trial","has_exemption":false,"start_date":"2022-06-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04042844","publication_url":"https://clinicaltrials.gov/study/NCT04042844","title":"A Phase 2, Double-Blind, Controlled, Randomized Study to Evaluate the Safety and Preliminary Efficacy of a Single Dose Intradiscal Injection of BRTX-100 for Patients With Chronic Lumbar Disc Disease (cLDD)","has_exemption":false,"start_date":"2022-06-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"BioRestorative Therapies","sponsor_slug":"biorestorative-therapies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05176626","publication_url":"https://clinicaltrials.gov/study/NCT05176626","title":"Long-term Effectiveness of the Antiobesity Medication Phentermine","has_exemption":false,"start_date":"2022-06-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05456425","publication_url":"https://clinicaltrials.gov/study/NCT05456425","title":"Multicenter, Double-Masked, Randomized, Vehicle-Controlled 12-Month Parallel Comparison of the Safety and Efficacy of 0.1% and 0.2% CBT-001 Versus Vehicle, Dosed Twice-Daily, in Patients With Pterygium","has_exemption":false,"start_date":"2022-06-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Cloudbreak Therapeutics, LLC","sponsor_slug":"cloudbreak-therapeutics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04785300","publication_url":"https://clinicaltrials.gov/study/NCT04785300","title":"ALSENLITE: An Open-Label Pilot Study of Senolytics for Alzheimer's Disease","has_exemption":false,"start_date":"2022-07-06","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04982796","publication_url":"https://clinicaltrials.gov/study/NCT04982796","title":"Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder","has_exemption":false,"start_date":"2022-07-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Portland VA Research Foundation, Inc","sponsor_slug":"portland-va-research-foundation-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05226871","publication_url":"https://clinicaltrials.gov/study/NCT05226871","title":"A TREATMENT PROTOCOL FOR PARTICIPANTS CONTINUING FROM PFIZER-SPONSORED PALBOCICLIB CLINICAL STUDIES","has_exemption":false,"start_date":"2022-07-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05392114","publication_url":"https://clinicaltrials.gov/study/NCT05392114","title":"An Open-Label, Long Term Safety and Efficacy Study of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)","has_exemption":false,"start_date":"2022-07-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Ionis Pharmaceuticals, Inc.","sponsor_slug":"ionis-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05475925","publication_url":"https://clinicaltrials.gov/study/NCT05475925","title":"A Multicenter, Open-Label, First-In-Human, Multiple Expansion Cohort, Phase 1/2 Study to Evaluate the Safety and Efficacy of DR-01 in Adult Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas","has_exemption":false,"start_date":"2022-07-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Dren Bio","sponsor_slug":"dren-bio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05396885","publication_url":"https://clinicaltrials.gov/study/NCT05396885","title":"A Phase II Study of CART-ddBCMA for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2022-07-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Kite, A Gilead Company","sponsor_slug":"kite-a-gilead-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05393622","publication_url":"https://clinicaltrials.gov/study/NCT05393622","title":"Intracalvarial Prefrontal Cortical Stimulation in Treatment-Resistant Depression","has_exemption":false,"start_date":"2022-07-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Inner Cosmos Inc","sponsor_slug":"inner-cosmos-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04796285","publication_url":"https://clinicaltrials.gov/study/NCT04796285","title":"A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor","has_exemption":false,"start_date":"2022-08-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05265000","publication_url":"https://clinicaltrials.gov/study/NCT05265000","title":"Transcutaneous Spinal Cord Stimulation for Chronic Low Back Pain","has_exemption":false,"start_date":"2022-08-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05463263","publication_url":"https://clinicaltrials.gov/study/NCT05463263","title":"An Open-Label, First in Human, Phase 1/2 to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of the CTPS1 Inhibitor STP938 In Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas","has_exemption":false,"start_date":"2022-08-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Step Pharma, SAS","sponsor_slug":"step-pharma-sas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05488054","publication_url":"https://clinicaltrials.gov/study/NCT05488054","title":"Use of a Wearable Muscle Oxygen Saturation Sensor in the Rehabilitation of High-School and Collegiate Athletes Recovering From Arthroscopic Hip and Knee Surgery","has_exemption":false,"start_date":"2022-08-08","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05073419","publication_url":"https://clinicaltrials.gov/study/NCT05073419","title":"Arrhythmia Detection After Myocardial Infarction Trial","has_exemption":false,"start_date":"2022-08-09","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Samir Saba","sponsor_slug":"samir-saba","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05603715","publication_url":"https://clinicaltrials.gov/study/NCT05603715","title":"Pyridostigmine for the Treatment of Constipation in Parkinson Disease","has_exemption":false,"start_date":"2022-08-10","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Vermont Medical Center","sponsor_slug":"university-of-vermont-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05478720","publication_url":"https://clinicaltrials.gov/study/NCT05478720","title":"DON in Pediatric Cerebral Malaria: A Phase I/IIa Dose-Escalation Safety Study","has_exemption":false,"start_date":"2022-08-16","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Douglas Postels, MD, MS","sponsor_slug":"douglas-postels-md-ms","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05464784","publication_url":"https://clinicaltrials.gov/study/NCT05464784","title":"A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of MN-001 in Patients Diagnosed With Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia","has_exemption":false,"start_date":"2022-08-22","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"MediciNova","sponsor_slug":"medicinova","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05455619","publication_url":"https://clinicaltrials.gov/study/NCT05455619","title":"Study to Assess the Safety and Efficacy of Evexomostat (SDX-7320) in Combination With A PI3K or Akt Inhibitor Plus Fulvestrant in Patients With HR+, HER2-, Metastatic Breast Cancer With PI3K Pathway Alteration(s)","has_exemption":false,"start_date":"2022-08-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"SynDevRx, Inc.","sponsor_slug":"syndevrx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05500222","publication_url":"https://clinicaltrials.gov/study/NCT05500222","title":"A Randomized Double-blind Placebo-controlled Phase 3 Study to Evaluate the Effect of Resmetirom on Liver-related Outcomes in Patients With Well-compensated (Child-Pugh A) Non-alcoholic Steatohepatitis (NASH) Cirrhosis (MAESTRO-NASH-OUTCOMES)","has_exemption":false,"start_date":"2022-08-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Madrigal Pharmaceuticals, Inc.","sponsor_slug":"madrigal-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06488001","publication_url":"https://clinicaltrials.gov/study/NCT06488001","title":"Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery","has_exemption":false,"start_date":"2022-08-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"United States Naval Medical Center, Portsmouth","sponsor_slug":"united-states-naval-medical-center-portsmouth","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05492123","publication_url":"https://clinicaltrials.gov/study/NCT05492123","title":"Randomized Phase II Study to Evaluate Induction Nivolumab-Ipilimumab, Followed by Nivolumab With Chemoradiotherapy Versus Chemoradiotherapy for Advanced Cervical Cancer","has_exemption":false,"start_date":"2022-08-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Hospital Israelita Albert Einstein","sponsor_slug":"hospital-israelita-albert-einstein","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04794582","publication_url":"https://clinicaltrials.gov/study/NCT04794582","title":"Prevention of Incisional Hernia After Renal Transplantation Using ProGrip Mesh","has_exemption":false,"start_date":"2022-08-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","sponsor_slug":"fundacion-para-la-investigacion-biomedica-del-hospital-universitario-ramon-y-cajal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05281471","publication_url":"https://clinicaltrials.gov/study/NCT05281471","title":"A Randomized Phase 3 Study Assessing the Efficacy and Safety of Olvi-Vec Followed by Platinum-doublet Chemotherapy and Bevacizumab Compared With Physician's Choice of Chemotherapy and Bevacizumab in Women With Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)","has_exemption":false,"start_date":"2022-08-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Genelux Corporation","sponsor_slug":"genelux-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05386108","publication_url":"https://clinicaltrials.gov/study/NCT05386108","title":"An Open-label Multicenter Phase 1b-2 Study of Elacestrant in Combination With Abemaciclib in Women and Men With Brain Metastasis From Estrogen Receptor Positive, HER-2 Negative Breast Cancer","has_exemption":false,"start_date":"2022-08-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Stemline Therapeutics, Inc.","sponsor_slug":"stemline-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05518500","publication_url":"https://clinicaltrials.gov/study/NCT05518500","title":"A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults","has_exemption":false,"start_date":"2022-08-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The Jackson Laboratory","sponsor_slug":"the-jackson-laboratory","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04211675","publication_url":"https://clinicaltrials.gov/study/NCT04211675","title":"A Phase I/II Safety Lead in Study of Ex-Vivo Expanded Allogeneic Universal Donor TGFβi NK Cell Infusions in Combination With Irinotecan, Temozolomide, and Dinutuximab in Patients With Relapsed or Refractory Neuroblastoma: The Allo - STING Trial","has_exemption":false,"start_date":"2022-09-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05582785","publication_url":"https://clinicaltrials.gov/study/NCT05582785","title":"Low Field Magnetic Resonance Imaging Assessment With Outpatients","has_exemption":false,"start_date":"2022-09-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Mercy Hospital Kansas City","sponsor_slug":"childrens-mercy-hospital-kansas-city","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04261738","publication_url":"https://clinicaltrials.gov/study/NCT04261738","title":"Effects of Hyperbaric Oxygen Therapy on Glucose Homeostasis in Patients Living With Diabetes Mellitus","has_exemption":false,"start_date":"2022-09-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Legacy Health System","sponsor_slug":"legacy-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04931017","publication_url":"https://clinicaltrials.gov/study/NCT04931017","title":"Metformin for Chemoprevention of Lung Cancer in High-Risk Overweight or Obese Individuals","has_exemption":false,"start_date":"2022-09-09","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null}]}